SB 120 (2019)
Summary:
Revises the regulation of the prescription drug monitoring program. For example, this allows bill de-identified data to be kept indefinitely for analytical purposes. The bill also transfers responsibility for the program from the Board of Pharmacy to the Office of Professional Licensure.
Bill Became Law?:
Yes
Status Detail:
Signed by Governor
